http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1336949-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ee5285e8e8edccb061046ff20da7a6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16 |
| filingDate | 1972-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1973-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1336949-A |
| titleOfInvention | Adenosine derivatives |
| abstract | 1336949 Adenosine derivatives BOEHRINGER MANNHEIM GmbH 3 July 1972 [6 July 1971] 30967/72 Heading C2C Novel compounds I and salts thereof in which A is C 1-5 alkyl or C 1-5 alkoxy, X is a bond or oxygen and n is 1 to 5 are prepared by reacting a 6-halopurine riboside with an amine of general Formula III The hydroxyl groups in the ribose residue are blocked by protective groups. Amines used are 2 - (2, 3 or 4 - methoxy - phenyl)cyclohexylamine, 2 - (2 - methyl - phenyl)cyclohexyl- or pentylamine or 2 - (3 - methoxy - phenyl)cyclopentylamine. Compounds I have a beneficial action on blood vessels and circulation and also lower the level of lipids in serum and they form with a solid or liquid diluent or carrier a pharmaceutical composition which may be administered orally or parenterally. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0232813-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0232813-A3 |
| priorityDate | 1971-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.